|
Type of diseases | Author | Differentiated status of DPSCs | Delivery method | Function of DPSCs | References |
|
The central nervous system (CNS) diseases |
|
Spinal cord injury (SCI) | Yamamoto et al. | Undifferentiated | DPSC transplantation | DPSCs inhibited massive SCI-induced apoptosis, preserved neural fibers and myelin, regenerated transected axons, and replaced damaged cells by differentiating into oligodendrocytes | [134] |
Yang et al. | Undifferentiated | DPSCs transplanted with cell pellets | DPSCs reduced inflammatory injury, promoted axonal regeneration, and reduced progressive hemorrhagic necrosis after SCI by inhibiting IL-1β, RhoA, and SUR1 expression | [136] |
Zhang et al. | Undifferentiated | DPSCs transplanted with chitosan-scaffold | DPSCs promoted motor functional recovery and inhibited cell apoptosis after SCI through secreting BDNF, GDNF, NT-3 and reducing the expression of active-caspase 3 | [137] |
|
Stroke | Song et al. | Undifferentiated | DPSCs cocultured with the conditioned medium in vitro | DPSCs conferred superior cytoprotection against cell death by reducing reactive gliosis and suppressing free radical and proinflammatory cytokine expression | [86] |
Song et al. | Undifferentiated | Intravenous DPSC injection | DPSCs reduced the infarct volume of SD rats after middle cerebral artery occlusion (MCAO) due to high angiogenesis and neurogenic differentiation and reduction of reactive gliosis | [87] |
Sugiyama et al. | Dental pulp-derived CD31(−)/CD146(−) side population (SP) stem cells | CD31(−)/CD146(−) SP cells transplantation | DPSCs promoted migration and differentiation of the endogenous neuronal progenitor cells and induced vasculogenesis and ameliorated ischemic brain injury of SD rats after transient middle cerebral artery occlusion (TMCAO) | [102] |
Yang et al. | Dental pulp-derived neuronal stem cells (tNSCs) | tNSC transplantation | Transplanted tNSC promoted function recovery after MCAO because of possessing hypoimmunogenic properties and immune modulation abilities | [142] |
Leong et al. | Undifferentiated | Intracerebral DPSC transplantation | DPSCs enhanced the recovery of poststroke sensorimotor deficits owing to differentiation into astrocytes and mediation through DPSC-dependent paracrine effects | [143] |
|
Parkinson’s disease (PD) | Kanafi et al. | Dopaminergic cell-type differentiated | DPSCs were induced in vitro | DPSCs showed efficient propensity towards functional dopaminergic cell type | [65] |
Chun et al. | Dopaminergic neurons differentiated | DPSCs were treated with the dopaminergic neuron differentiation kit in vitro | DPSCs could differentiate into dopaminergic neural cells under experimental cell differentiation conditions | [69] |
Gnanasegaran et al. | Undifferentiated | Intrathecal DPSC transplantation into a mouse model of PD in vitro | DPSCs could treat the PD by regulating inflammatory mediators such as reducing the secretions of proinflammatory factors (IL-1α, IL-1β, IL6, IL8, and TNF-α) and upregulating the expression levels of anti-inflammatory factors (IL2, IL4, and TNF-β) | [146] |
Gnanasegaran et al. | DAergic-like cells differentiated | DPSCs were cultured in a system which consists of neuron and microglia in vitro | DPSCs were shown to have immunomodulatory capacities to reduce 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- (MPTP-) induced deficits such as reactive oxygen species, DNA damages, and nitric oxide release | [147] |
|
Alzheimer’s disease (AD) | Wang et al. | Undifferentiated | DPSCs cocultured with okadaic acid- (OA-) induced cellular model of AD in vitro | DPSC-treated cells had the morphology of restored neurons, elongated dendrites, densely arranged microfilaments, and thickened microtubular fibrils | [154] |
Ahmed et al. | Undifferentiated | DPSCs cocultured with amyloid beta (Aβ) peptide-induced cellular model of AD in vitro | DPSCs secreted and produced numerous vascular endothelial growth factor (VEGF), fractalkine, RANTES, fms-related tyrosine kinase 3 (FLT-3), and monocyte chemotactic protein 1 (MCP-1) | [155] |
|
Retinal injury | Mead et al. | Undifferentiated | Intravitreal DPSC transplantation | DPSCs produced and secreted lots of neurotrophins in order to promote neuritogenesis/axogenesis of retinal cells | [83] |
Mead et al. | Undifferentiated | Intravitreal DPSC transplantation | DPSC provided protection from retinal ganglion cell (RGC) loss and retinal nerve fiber layer thickness (RNFL) thinning and preserved RGC function | [160] |
Bray et al. | Undifferentiated | DPSCs cocultured with the conditioned media which were obtained from organotypic explants from damaged rat retinas in vitro | DPSCs had ability to promote neurodifferentiation and expression of retinal neuronal markers in order to cure the rat retinas | [161] |
|
The peripheral nervous system (PNS) diseases |
|
Facial nerve defect | Sasaki et al. | Undifferentiated | DPSCs transplanted with poly-DL-lactide-coglycolide (PLGA) and collagen gel | DPSCs promoted the axon regeneration and myelinated nerve formation | [173] |
Sciatic nerve defect | Sanen et al. | Schwann cell-type differentiated | DPSCs transplanted with NeuraWrap™ conduits | DPSCs promoted in growing neurites, myelinated nerve, and newly blood vessel formation and survival | [174] |
Sciatic nerve defect | Askari et al. | Oligodendrocyte progenitor cell- (OPC-) type differentiated | DPSC-induced OPC transplantation | DPSCs could be differentiated into functional oligodendrocytes | [175] |
Sciatic nerve defect | Omi et al. | Undifferentiated | DPSC transplantation | DPSCs increased the gene expression of interleukin-10 and promoted macrophages polarization towards anti-inflammatory M2 phenotypes | [176] |
|